19,603 Shares in Avantor, Inc. (NYSE:AVTR) Acquired by Fifth Third Wealth Advisors LLC

Fifth Third Wealth Advisors LLC purchased a new stake in Avantor, Inc. (NYSE:AVTR) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 19,603 shares of the company’s stock, valued at approximately $507,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. SG Americas Securities LLC purchased a new stake in shares of Avantor during the 1st quarter worth $159,000. Acadian Asset Management LLC increased its stake in Avantor by 45.8% in the first quarter. Acadian Asset Management LLC now owns 22,678 shares of the company’s stock valued at $579,000 after purchasing an additional 7,120 shares during the period. UniSuper Management Pty Ltd increased its stake in shares of Avantor by 97.9% during the first quarter. UniSuper Management Pty Ltd now owns 9,500 shares of the company’s stock worth $243,000 after acquiring an additional 4,700 shares during the period. CANADA LIFE ASSURANCE Co increased its stake in shares of Avantor by 0.6% during the first quarter. CANADA LIFE ASSURANCE Co now owns 553,982 shares of the company’s stock worth $14,168,000 after acquiring an additional 3,038 shares during the period. Finally, Westwood Holdings Group Inc. increased its stake in shares of Avantor by 10.5% during the first quarter. Westwood Holdings Group Inc. now owns 723,084 shares of the company’s stock worth $18,489,000 after acquiring an additional 68,541 shares during the period. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Insider Buying and Selling

In related news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the sale, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. This trade represents a 10.66 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.30% of the stock is owned by corporate insiders.

Avantor Stock Performance

Shares of AVTR opened at $20.14 on Thursday. The stock has a market cap of $13.71 billion, a price-to-earnings ratio of 43.78, a PEG ratio of 2.52 and a beta of 1.35. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The company has a 50-day moving average of $24.14 and a two-hundred day moving average of $23.91. Avantor, Inc. has a one year low of $19.49 and a one year high of $28.00.

Analyst Ratings Changes

Several analysts have issued reports on the stock. TD Cowen upped their price target on shares of Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a report on Monday, July 29th. Royal Bank of Canada reissued an “outperform” rating and issued a $34.00 price objective on shares of Avantor in a research report on Thursday, September 26th. Stifel Nicolaus upped their target price on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Wells Fargo & Company reduced their price objective on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Finally, Barclays reduced their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $27.57.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.